Search form
Search
Login
Subscribe
Home
Country Intelligence
Industry Directory
Offsets / IC
Tenders
Haiti
(0/week)
Guyana
(0/week)
Honduras
(0/week)
Jamaica
(0/week)
Netherlands Antilles
(0/week)
View all
(0/week)
News
United States
(1226/week)
Manufacturing
(603/week)
Technology
(1147/week)
Energy
(435/week)
aviation
(185/week)
Events
About us
Who we are
Our People
Partners
Contact us
LinkedIn
Login
Twitter
Register
Home
News
Joseph C. Papa
Apr 30, 2020
Bausch Health To Participate at 2020 Bank of America Merrill Lynch Global Healthcare Conference
Jan 06, 2020
Bausch Health To Participate At The 38th Annual J.P. Morgan Healthcare Conference
Dec 16, 2019
Bausch Health Resolves "Stock Drop" Litigation Initially Filed in October 2015
Aug 29, 2019
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
May 29, 2019
Bausch Health Companies Announces Participation in Upcoming Investor Conferences
Apr 24, 2019
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
Mar 06, 2019
Bausch Health Completes Acquisition Of Certain Assets Of Synergy Pharmaceuticals Inc.
Feb 26, 2019
Bausch Health to Acquire Certain Assets of Synergy Pharmaceuticals Inc.
Feb 19, 2019
Bausch Health Acquires Eton Pharmaceuticals' EM-100 Investigational Eye Drop For The Treatment Of Itchy Eyes Associated With Allergies
Feb 01, 2019
Bausch Health Companies Announces Participation In Upcoming Investor Conferences
Jan 29, 2019
Bausch Health Reduces Debt By Additional $100 Million
Jan 07, 2019
Bausch Health Provides Company Update At The 37th Annual J.P. Morgan Healthcare Conference
Jan 02, 2019
Bausch Health To Present At The 37th Annual J.P. Morgan Healthcare Conference
Dec 12, 2018
Bausch Health Enters Into Definitive "Stalking Horse" Agreement To Acquire Substantially All The Assets Of Synergy Pharmaceuticals Inc.
Nov 30, 2018
Bausch Health Announces Redemption Of $200 Million Aggregate Principal Amount Of Its Outstanding 5.625% Senior Notes Due 2021
Nov 19, 2018
Bausch Health Announces Participation In Upcoming Investor Conferences
Oct 30, 2018
Dr. Andrew C. Von Eschenbach Joins Bausch Health Board Of Directors
Jun 19, 2018
SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Valeant Pharmaceuticals International, Inc. - VRX
Jun 18, 2018
FDA Issues Complete Response Letter For DUOBRII(TM) (Halobetasol Propionate and Tazarotene) Lotion
May 10, 2018
Valeant To Participate At 2018 Bank Of America Merrill Lynch Healthcare Conference
Page 1
››
Latest News
Jun 18, 2025
SLR Credit Solutions Agents Senior Credit Facility for Velocity One
Jun 18, 2025
NuScale Advances Clean Water and Hydrogen Production with Breakthrough Research
Jun 18, 2025
The Chemours Company Provides Update on Second Quarter 2025 Outlook
Jun 18, 2025
Matador Resources Company Announces Date of Second Quarter 2025 Earnings Release
Jun 18, 2025
Vi and AST SpaceMobile Announce Partnership for Satellite Connectivity
Jun 18, 2025
Audax Private Equity’s Origins Strategy Completes Thermogenics Exit
Jun 18, 2025
Cytiva and Argonaut Collaborate to Expand Reagent Lyophilization Manufacturing in EU and US
Jun 18, 2025
SkyWest Orders 60 New Embraer E175 Aircraft
View all News
Agenda
30
September
Portugal
Troia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United Kingdom
London, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events